CLSTN1 and Alzheimer disease: Several studies on the calsyntenin-1 CSF levels reported an association of the protein with FTLD; specifically, it was found that calsyntenin-1 CSF levels were lower in patients affected by FTLD compared to AD and cognitively normal controls [59,60,61].